Program

ABOUT THE BIOTECH CEO SUMMITS – UNLIKE ANY OTHER CONFERENCE

The Biotech CEO Summits are unlike most other meetings CEOs attend. The Summits focus on the participating CEOs discussing issues of importance to them as leaders of companies they want to position for growth and success. The Summits are discussion based meetings led by subject matter experts. All participants are invited to, and indeed encouraged to join the discussions by asking questions and sharing their personal insights. The Summits are run under Chatham House Rules to encourage open and frank conversation. The media are not invited, and the sessions are not recorded, to provide an extra layer of privacy.

2024 Agenda

Monday, July 15

 2:00 pm

Registration Opens: Maurice Braun Foyer

3:00 pm

Pre-Event: Gathering for Female Biotech CEOs: Charles Fries Room

  • Katherine Andersen, Head, Life Science & Healthcare, HSBC Innovation Banking
  • Sandra Dunn, CEO & Founder, Phoenix Molecular Designs
  • Elizabeth Jeffords, CEO, Iolyx Therapeutics
 4:30 pm

Welcome Networking Event: Arroyo Terrace
Drinks and Falconry Demonstration

 6:00 pm

Opening Program: Everett Jackson Room
Welcome Remarks

  • Sara Jane Demy, Founder & CEO, Demy-Colton
 6:15 pm

CEO Summit Participant Introductions 
SelfIntroductions by all participants  

 7:30 pm

Fireside Chat Series: The Purposeful CEO – Fulfilling the Promise

  • Moderator: Karen Deschaine, Partner, Wilson Sonsini
  • Fireside Chat CEO: Sabrina Johnson, President & CEO, Daré Bioscience
 8:15 pm

Networking Reception & Dinner: Alfred Mitchell Room

Tuesday, July 16

 7:00 am

Private Networking Breakfast: Charles Reiffel Room

 8:20 am

Summit Overview & Rules of Engagement: Maurice Braun Room

  • Sara Jane Demy, Founder & CEO, Demy-Colton
 8:30 am

Opening Discussion: The Financial Environment – Let’s Assess Where We Are Today

Discussion Leader:

  • Evonne Sepsis, Managing Director, ESC Advisors

Discussants:

  • Jonathan Norris, Managing Director, HSBC Innovation Banking
  • Charles Rohaut, Managing Director, Life Sciences & Technology, ZRG Partners
 9:15 am

Light at the End of Tunnel: Refocusing on Growth

Discussion Leader:

  • Katherine Andersen, Head, Life Science & Healthcare, HSBC Innovation Banking

Discussants:

  • William Newell, CEO, Sutro Biopharma
  • Evonne Sepsis, Managing Director, ESC Advisors
  • Thijs Spoor, CEO, Perspective Therapeutics
10:00 am Networking Break: Maurice Braun Patio
10:15 am

Alternative Forms of Capital: Considering the Options

Discussion Leader:

  • Kate Walsh, Managing Director, HSBC Innovation Banking

Discussants:

  • Mark Federici, Global Director, Business Development, Bio-innovations, Thermo Fisher Scientific
  • Mike Webb, CEO, Epion Therapeutics, Inc.
11:00 am

Valuation: How Do Investors and Partners Value Your Enterprise and Key Assets 

Discussion Leader:

  • Ted Haack, Vice President, LatticePoint

Discussants:

  • Renée Aguilar-Lucander, CEO, Calliditas Therapeutics
  • Jeffrey Cleland, Chairman, President & CEO, Ashvattha Therapeutics
  • Elizabeth Jeffords, CEO, Iolyx Therapeutics
  • Ravi Kiron, CEO, Cytovia Therapeutics
11:45 am

AI in Biopharma: Changing our Sector and How to Navigate It

Discussion Leader:

  • Ryan Roller, Managing Director, Life Science & Healthcare, HSBC Innovation Banking

Discussants:

  • Jacob Berlin, CEO, Terray Therapeutics
  • Allison Murphy, Head, Growth & Channel Sales, Corval
  • Avi Veidman, CEO, Nucleai
12:30 pm

Networking Lunch: Arroyo Terrace

1:45 pm

Valuation Case Study Overview

Discussion Leaders:

  • Deanna Angello, Executive-in-Residence, Springboard Enterprises
  • Kerrie Brady, Former CEO, OccuTerra
  • Ted Haack, Vice President, LatticePoint
2:00 pm

Valuation Case Study Breakout: Charles Fries Room & Charles Reiffel Room

2:45 pm

Valuation Report Back: Maurice Braun Room

Discussion Leaders:

  • Deanna Angello, Executive in Residence, Springboard Enterprises
  • Kerrie Brady, Former CEO, OccuTerra
  • Ted Haack, Vice President, LatticePoint
 3:15 pm

Fireside Chat Series: The Purposeful CEO – Fulfilling the Promise

Moderator:

  • Seema Kumar, CEO, Cure

Fireside Chat CEO:

  • William Newell, CEO, Sutro Biopharma
4:00 pm

Embracing Change: Weathering the Storm in DC

Discussion Leader:

  • Deborah Smith, Partner, Wilson Sonsini

Discussants:

  • Jeffrey Cleland, Chairman, President & CEO, Ashvattha Therapeutics
  • Elizabeth Jeffords, CEO, Iolyx Therapeutics
  • William Newell, CEO, Sutro Biopharma
 5:00 pm

Day 1 Wrap-Up & Instructions for CEO Summit Games

  • Sara Jane Demy, Founder & CEO, Demy-Colton
  • Kari Bennett, Senior Marketing Advisor, Demy-Colton
 5:15 pm Biotech CEO Summit Games: Arroyo Terrace
7:15 pm Break
7:45 pm Networking Reception: Charles Fries Patio
 8:30 pm Biotech CEO Summit Gala Awards & Dinner: Charles Reiffel Room

Wednesday, July 17

 7:00 am

Private Networking Breakfast: Charles Reiffel Room

 8:45 am

Welcome Back & Day 2 Commences:  Maurice Braun Room

  • Sara Jane Demy, Founder & CEO, Demy-Colton
 9:00 am

Communications: The CEO Has to Get it Right, Every Time

Discussion Leader:

  • Jason Spark, President, Biotech, Inizio Evoke Comms

Discussants:

  • Renée Aguilar-Lucander, CEO, Calliditas Therapeutics AB
  • Rachelle Jacques, Former CEO, Akari Therapeutics
 9:45 am

The Board: Putting a Plan in Place to Evolve Your Board as Your Company Advances

Discussion Leader:

  • David Fortier, Managing Partner, Global Head of Partner Recruitment, ZRG Partners

Discussants:

  • Jeffrey Cleland, CEO, Ashvattha Therapeutics, Inc.
  • Beth Hoffman, CEO, Origami Therapeutics
  • Thijs Spoor, CEO, Perspective Therapeutics
10:30 am Networking Break: Maurice Braun Patio
11:00 am

Leadership: Shaping Strategy to Manage all Binary Outcomes

Discussion Leader:

  • Kerrie Brady, Former CEO, OcuTerra Therapeutics

Discussants:

  • Sabrina Johnson, President & CEO, Daré Bioscience        
  • Jason Spark, President, Biotech, Inizio Evoke Comms
11:45 am

Value Creation through Retention: Developing Top Talent and Building a Strong Organizational Culture

Discussion Leader:

  • Angela Hamilton, Managing Director, Consulting Solutions, ZRG Partners

Discussants:

  • Grant Gephardt, Senior Director, Global Corporate Accounts, Thermo Fisher Scientific
  • Shalabh Gupta, CEO, Unicycive Therapeutics, Inc.
12:30 pm

Networking Lunch: Arroyo Terrace

 2:00 pm

An Unguarded Conversation Among Friends

  • Sara Jane Demy, Founder & CEO, Demy-Colton
 2:45 pm

Closing Reception: Charles Fries Patio

 

 

List of 2024 Discussants

  • Katherine Andersen, Head of Life Science & Healthcare, HSBC Innovation Banking*
  • Deanna Angello, Executive in Residence, Springboard Enterprises
  • Karen Deschaine, Partner, Wilson Sonsini
  • Jesse Essaff, Relationship Manager, HSBC Innovation Banking
  • Mark Federici, Global Director, Business Development for Bio-innovations, Thermo Fisher Scientific
  • David Fortier, Managing Partner & Co-Leader, Global Healthcare & Life Sciences Practice, ZRG Partners*
  • Grant Gephardt, Senior Director Global Corporate Accounts, Thermo Fisher Scientific
  • Ted Haack, Vice President, LatticePoint
  • Angela Hamilton, Managing Director, Consulting Solutions, ZRG Partners
  • Sabrina Johnson, President & CEO, Daré Bioscience
  • Seema Kumar, CEO, Cure
  • Allison Murphy, Head, Growth & Channel Sales, Corval
  • William Newell, CEO, Sutro Biopharma*
  • Jonathan Norris, Managing Director, HSBC Innovation Banking
  • Joe Panetta, CEO, Biocom California
  • Charles Rohaut, Managing Director, Life Sciences & Technology, ZRG Partners
  • Ryan Roller, Managing Director, Life Science & Healthcare, HSBC Innovation Banking
  • Evonne Sepsis, Managing Director, ESC Advisors
  • Deborah Smith, Partner, Wilson Sonsini
  • Jason Spark, President, Biotech, Inizio Evoke Comms
  • Kate Walsh, Managing Director, HSBC Innovation Banking
* Advisory Board Member